Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
Symbol: CANF (NYSE)
0.63
▲ (1.36%) 0.008
Company Description:
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
Key Stats
- Today's Open: $0.625
- Today's High: $0.67
- Today's Low: $0.602
- Today's Volume: 79.02K
- Yesterday Close: $0.6176
- Yesterday High: $0.64
- Yesterday Low: $0.6126
- Yesterday Volume: 123.83K
- Last Min Volume: 4
- Last Min High: $0.626
- Last Min Low: $0.626
- Last Min VWAP: $0.626
Company Profile
- Name: Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
- Website: http://www.canfite.com
- Listed Date: 2012-09-10
- Location: ,
- Market Status: Active
- CIK Number: 0001536196
- SIC Code:
- SIC description:
- Market Cap: $9.74M
- Round Lot: 100
- Outstanding Shares: 15.77M
- Asset Type: ADRC
RECENT FILINGS FOR CANF
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-15 | 6-K | View |
| 2025-09-11 | EFFECT | View |
| 2025-09-11 | EFFECT | View |
| 2025-09-08 | POS AM | View |
| 2025-09-08 | POS AM | View |
| 2025-09-08 | POS AM | View |
| 2025-09-08 | POS AM | View |
| 2025-08-28 | POS AM | View |
| 2025-08-28 | POS AM | View |
| 2025-08-28 | 6-K | View |
| 2025-07-30 | 6-K | View |
| 2025-07-29 | 424B4 | View |
| 2025-07-29 | 6-K | View |
| 2025-07-28 | EFFECT | View |
| 2025-07-28 | 6-K | View |
| 2025-07-28 | 6-K | View |
| 2025-07-25 | F-1/A | View |
| 2025-07-24 | CORRESP | View |
| 2025-07-24 | CORRESP | View |
| 2025-07-23 | F-1 | View |
Latest News on CANF